Why The Corbus Pharmaceuticals Holdings Inc (CRBP) Cystic Fibrosis Results Are Very Positive
Last week, Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) announced data from a Phase II study of its lead development asset Anabasum.
Posts Tagged ‘Is CRBP A Good Stock To Buy Right Now?’
Corbus Pharmaceuticals Holdings Inc (CRBP) Share Offering Hints At $7 Floor With Threatening Short Squeeze
In most cases, equity financings below market are bad news for shareholders. There are exceptions though.
Biotech Movers And Shakers: Corbus Pharmaceuticals Holdings Inc (CRBP) And Galena Biopharma Inc (GALE)
Last week was a wild ride for a number of companies in the biotech space, with the U.S election bringing with it an initial wave of uncertainty, followed by the realization that...
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Completes Cystic Fibrosis Enrollment as Stock Explodes Higher
Something is happening with Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP). Since February, the stock has risen 600%, 158% since August alone.
Why Corbus Pharmaceuticals Holdings Inc (CRBP) Climbed 23% This Week
Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP), a Market Exclusive favorite, has been on a 23% tear since Tuesday, August 16.
Insider And Smart Money Move Into Corbus Pharmaceuticals As Pipeline Progresses
For institutional holders, the biggest gains in terms of percentage per holding are made in the smaller companies.
